Clinical Trials on Malignant Melanoma
Total 7169 results
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Unknown
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Inge Marie SvaneCopenhagen University Hospital at HerlevTerminated
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Scancell LtdTerminated
-
Hoffmann-La RocheCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Oslo University HospitalCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance
-
Uppsala UniversityUppsala University HospitalCompletedMalignant MelanomaSweden
-
Medivation, Inc.CompletedMelanoma | Malignant MelanomaUnited States, Israel
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
University Hospital TuebingenCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBioNumerik Pharmaceuticals, Inc.Terminated
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
MedImmune LLCCompletedMalignant MelanomaUnited States
-
SciBase ABCompleted
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Rigshospitalet, DenmarkCompleted
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompletedCutaneous Malignant MelanomaBelgium, Hungary
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Quanli GaoNot yet recruiting
-
Inge Marie SvaneTechnical University of DenmarkRecruiting
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
Universitair Ziekenhuis BrusselRecruitingMalignant MelanomaBelgium
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County... and other collaboratorsCompleted
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchTerminated
-
4SC AGCompletedMalignant MelanomaGermany, Italy